External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry

We aimed to perform external validation of the recently developed survival prediction model for diffuse intrinsic pontine glioma (DIPG), and discuss its utility. The DIPG survival prediction model was developed in a cohort of patients from the Netherlands, United Kingdom and Germany, registered in t...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of neuro-oncology Ročník 134; číslo 1; s. 231 - 240
Hlavní autoři:	Veldhuijzen van Zanten, Sophie E. M., Lane, Adam, Heymans, Martijn W., Baugh, Joshua, Chaney, Brooklyn, Hoffman, Lindsey M., Doughman, Renee, Jansen, Marc H. A., Sanchez, Esther, Vandertop, William P., Kaspers, Gertjan J. L., van Vuurden, Dannis G., Fouladi, Maryam, Jones, Blaise V., Leach, James
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New York Springer US 01.08.2017 Springer Nature B.V
Témata:	Adolescent Brain cancer Brain Stem Neoplasms - diagnostic imaging Brain Stem Neoplasms - mortality Brain Stem Neoplasms - therapy Brain tumors Calibration Chemotherapy Child Child, Preschool Clinical Study Cohort Studies Female Glioma Glioma - diagnostic imaging Glioma - mortality Glioma - therapy Humans Image Processing, Computer-Assisted Infant Infant, Newborn Kaplan-Meier Estimate Magnetic Resonance Imaging Male Medicine Medicine & Public Health Neurology Oncology Prognosis Registries Regression Analysis Risk groups Survival Cox proportional hazards modeling Discrimination Calibration External validation Prognostic modeling
ISSN:	0167-594X, 1573-7373, 1573-7373
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	We aimed to perform external validation of the recently developed survival prediction model for diffuse intrinsic pontine glioma (DIPG), and discuss its utility. The DIPG survival prediction model was developed in a cohort of patients from the Netherlands, United Kingdom and Germany, registered in the SIOPE DIPG Registry, and includes age <3 years, longer symptom duration and receipt of chemotherapy as favorable predictors, and presence of ring-enhancement on MRI as unfavorable predictor. Model performance was evaluated by analyzing the discrimination and calibration abilities. External validation was performed using an unselected cohort from the International DIPG Registry, including patients from United States, Canada, Australia and New Zealand. Basic comparison with the results of the original study was performed using descriptive statistics, and univariate- and multivariable regression analyses in the validation cohort. External validation was assessed following a variety of analyses described previously. Baseline patient characteristics and results from the regression analyses were largely comparable. Kaplan–Meier curves of the validation cohort reproduced separated groups of standard (n = 39), intermediate (n = 125), and high-risk (n = 78) patients. This discriminative ability was confirmed by similar values for the hazard ratios across these risk groups. The calibration curve in the validation cohort showed a symmetric underestimation of the predicted survival probabilities. In this external validation study, we demonstrate that the DIPG survival prediction model has acceptable cross-cohort calibration and is able to discriminate patients with short, average, and increased survival. We discuss how this clinico-radiological model may serve a useful role in current clinical practice.
AbstractList	We aimed to perform external validation of the recently developed survival prediction model for diffuse intrinsic pontine glioma (DIPG), and discuss its utility. The DIPG survival prediction model was developed in a cohort of patients from the Netherlands, United Kingdom and Germany, registered in the SIOPE DIPG Registry, and includes age <3 years, longer symptom duration and receipt of chemotherapy as favorable predictors, and presence of ring-enhancement on MRI as unfavorable predictor. Model performance was evaluated by analyzing the discrimination and calibration abilities. External validation was performed using an unselected cohort from the International DIPG Registry, including patients from United States, Canada, Australia and New Zealand. Basic comparison with the results of the original study was performed using descriptive statistics, and univariate- and multivariable regression analyses in the validation cohort. External validation was assessed following a variety of analyses described previously. Baseline patient characteristics and results from the regression analyses were largely comparable. Kaplan-Meier curves of the validation cohort reproduced separated groups of standard (n = 39), intermediate (n = 125), and high-risk (n = 78) patients. This discriminative ability was confirmed by similar values for the hazard ratios across these risk groups. The calibration curve in the validation cohort showed a symmetric underestimation of the predicted survival probabilities. In this external validation study, we demonstrate that the DIPG survival prediction model has acceptable cross-cohort calibration and is able to discriminate patients with short, average, and increased survival. We discuss how this clinico-radiological model may serve a useful role in current clinical practice.We aimed to perform external validation of the recently developed survival prediction model for diffuse intrinsic pontine glioma (DIPG), and discuss its utility. The DIPG survival prediction model was developed in a cohort of patients from the Netherlands, United Kingdom and Germany, registered in the SIOPE DIPG Registry, and includes age <3 years, longer symptom duration and receipt of chemotherapy as favorable predictors, and presence of ring-enhancement on MRI as unfavorable predictor. Model performance was evaluated by analyzing the discrimination and calibration abilities. External validation was performed using an unselected cohort from the International DIPG Registry, including patients from United States, Canada, Australia and New Zealand. Basic comparison with the results of the original study was performed using descriptive statistics, and univariate- and multivariable regression analyses in the validation cohort. External validation was assessed following a variety of analyses described previously. Baseline patient characteristics and results from the regression analyses were largely comparable. Kaplan-Meier curves of the validation cohort reproduced separated groups of standard (n = 39), intermediate (n = 125), and high-risk (n = 78) patients. This discriminative ability was confirmed by similar values for the hazard ratios across these risk groups. The calibration curve in the validation cohort showed a symmetric underestimation of the predicted survival probabilities. In this external validation study, we demonstrate that the DIPG survival prediction model has acceptable cross-cohort calibration and is able to discriminate patients with short, average, and increased survival. We discuss how this clinico-radiological model may serve a useful role in current clinical practice. We aimed to perform external validation of the recently developed survival prediction model for diffuse intrinsic pontine glioma (DIPG), and discuss its utility. The DIPG survival prediction model was developed in a cohort of patients from the Netherlands, United Kingdom and Germany, registered in the SIOPE DIPG Registry, and includes age <3 years, longer symptom duration and receipt of chemotherapy as favorable predictors, and presence of ring-enhancement on MRI as unfavorable predictor. Model performance was evaluated by analyzing the discrimination and calibration abilities. External validation was performed using an unselected cohort from the International DIPG Registry, including patients from United States, Canada, Australia and New Zealand. Basic comparison with the results of the original study was performed using descriptive statistics, and univariate- and multivariable regression analyses in the validation cohort. External validation was assessed following a variety of analyses described previously. Baseline patient characteristics and results from the regression analyses were largely comparable. Kaplan–Meier curves of the validation cohort reproduced separated groups of standard (n = 39), intermediate (n = 125), and high-risk (n = 78) patients. This discriminative ability was confirmed by similar values for the hazard ratios across these risk groups. The calibration curve in the validation cohort showed a symmetric underestimation of the predicted survival probabilities. In this external validation study, we demonstrate that the DIPG survival prediction model has acceptable cross-cohort calibration and is able to discriminate patients with short, average, and increased survival. We discuss how this clinico-radiological model may serve a useful role in current clinical practice.
Author	Kaspers, Gertjan J. L. van Vuurden, Dannis G. Lane, Adam Jansen, Marc H. A. Leach, James Jones, Blaise V. Sanchez, Esther Chaney, Brooklyn Fouladi, Maryam Doughman, Renee Vandertop, William P. Heymans, Martijn W. Veldhuijzen van Zanten, Sophie E. M. Hoffman, Lindsey M. Baugh, Joshua
Author_xml	– sequence: 1 givenname: Sophie E. M. orcidid: 0000-0002-3888-0977 surname: Veldhuijzen van Zanten fullname: Veldhuijzen van Zanten, Sophie E. M. email: s.veldhuijzen@vumc.nl organization: Department of Paediatrics, Division of Oncology/Haematology, VU University Medical Center (VUmc), Department of Paediatric Oncology/Haematology, VU University Medical Center – sequence: 2 givenname: Adam surname: Lane fullname: Lane, Adam organization: Department of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center – sequence: 3 givenname: Martijn W. surname: Heymans fullname: Heymans, Martijn W. organization: Department of Epidemiology and Biostatistics, VU University Medical Center (VUmc) – sequence: 4 givenname: Joshua surname: Baugh fullname: Baugh, Joshua organization: Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center – sequence: 5 givenname: Brooklyn surname: Chaney fullname: Chaney, Brooklyn organization: Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center – sequence: 6 givenname: Lindsey M. surname: Hoffman fullname: Hoffman, Lindsey M. organization: Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center – sequence: 7 givenname: Renee surname: Doughman fullname: Doughman, Renee organization: Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center – sequence: 8 givenname: Marc H. A. surname: Jansen fullname: Jansen, Marc H. A. organization: Department of Paediatrics, Division of Oncology/Haematology, VU University Medical Center (VUmc) – sequence: 9 givenname: Esther surname: Sanchez fullname: Sanchez, Esther organization: Department of Radiology & Nuclear Medicine, VU University Medical Center (VUmc) – sequence: 10 givenname: William P. surname: Vandertop fullname: Vandertop, William P. organization: Department of Neurosurgery, Neurosurgical Center Amsterdam – sequence: 11 givenname: Gertjan J. L. surname: Kaspers fullname: Kaspers, Gertjan J. L. organization: Department of Paediatrics, Division of Oncology/Haematology, VU University Medical Center (VUmc), Academy of Princess Máxima Center for Pediatric Oncology – sequence: 12 givenname: Dannis G. surname: van Vuurden fullname: van Vuurden, Dannis G. organization: Department of Paediatrics, Division of Oncology/Haematology, VU University Medical Center (VUmc) – sequence: 13 givenname: Maryam surname: Fouladi fullname: Fouladi, Maryam organization: Department of Epidemiology and Biostatistics, VU University Medical Center (VUmc) – sequence: 14 givenname: Blaise V. surname: Jones fullname: Jones, Blaise V. organization: Department of Radiology, Cincinnati Children’s Hospital Medical Center – sequence: 15 givenname: James surname: Leach fullname: Leach, James organization: Department of Radiology, Cincinnati Children’s Hospital Medical Center
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28560664$$D View this record in MEDLINE/PubMed
BookMark	eNp9ks9q3DAQxkVJaTZpH6CXIuilF7eSbVlWD4WSbtOFQEL_QG9ClsYbBVtyJHtpXqrPWNmbhiTQgkCC-X7fjGbmCB047wChl5S8pYTwd5FSUpGMUJ7ljJaZeIJWlPEi4wUvDtCK0IpnTJQ_D9FRjFeEkJIX9Bk6zGtWkaoqV-j3-tcIwakO71RnjRqtd9i3eLwEbGzbThGwdWOwLlqNB-9G6wBvO-t7heMUdjZxeAhgrF7Y3hvo3mOFte861fiQLHeAAww-jLgNvl-8N25JOyOJ_7S5OMVfYWvjGG6wcmbRfNucX6wfxp6jp63qIry4vY_Rj8_r7ydfsrPz083Jx7NMl5yMmRK00iTnTIgG6nRYrRtqaA61ZoUp0v9N6o0wpjKkIaaEgimiVJ5egkFVHKMPe99hanowGlILVCeHYHsVbqRXVj6MOHspt34nGSuLnMwGb24Ngr-eII6yt1FDaokDP0VJBSlzIuq8TtLXj6RXfppHMqtyxquqELPq1f2K7kr5O8okoHuBDj7GAO2dhBI5r4vcr4tM6yLndZEiMfwRo-24DCV9ynb_JfM9GVMWt4Vwr-h_Qn8ABKTXOQ
CitedBy_id	crossref_primary_10_1038_s41598_020_67764_2 crossref_primary_10_1007_s00381_020_04589_4 crossref_primary_10_3390_cancers13091989 crossref_primary_10_3390_children11040492 crossref_primary_10_1007_s00401_018_1936_6 crossref_primary_10_1158_1078_0432_CCR_19_3538 crossref_primary_10_1177_08465371221109921 crossref_primary_10_1007_s11060_021_03763_1 crossref_primary_10_1016_j_neurol_2023_03_016 crossref_primary_10_3389_fmed_2023_1071447 crossref_primary_10_1007_s10014_024_00493_w crossref_primary_10_1016_j_ijrobp_2025_05_063 crossref_primary_10_1093_neuonc_noaa140 crossref_primary_10_1007_s10555_019_09824_2 crossref_primary_10_1093_neuonc_noab140 crossref_primary_10_1080_14737175_2020_1775584 crossref_primary_10_1093_neuonc_noac123 crossref_primary_10_1093_neuonc_noaf058 crossref_primary_10_1016_j_drup_2019_06_001 crossref_primary_10_3390_medicines7050029 crossref_primary_10_1007_s00018_017_2714_7 crossref_primary_10_1007_s11060_017_2575_9 crossref_primary_10_1007_s11912_019_0783_5
Cites_doi	10.1007/s00401-007-0243-4 10.1007/s00401-015-1478-0 10.18637/jss.v045.i02 10.1007/s11060-011-0704-4 10.1016/S1470-2045(06)70615-5 10.1373/clinchem.2008.115345 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5 10.1136/bmj.b605 10.1093/neuonc/noq200 10.1159/000120511 10.1016/j.jclinepi.2009.03.017 10.1002/sim.4242 10.1007/s00401-016-1567-8 10.1016/j.jns.2009.03.009 10.1093/neuonc/nou104 10.1186/1471-2288-13-33 10.1136/bmj.b604 10.1586/14737140.2015.974563 10.1007/s11060-017-2372-5 10.1186/1471-2288-14-40 10.1007/s11060-016-2363-y 10.1002/cncr.23584 10.1093/neuonc/now101
ContentType	Journal Article
Copyright	The Author(s) 2017 Journal of Neuro-Oncology is a copyright of Springer, 2017.
Copyright_xml	– notice: The Author(s) 2017 – notice: Journal of Neuro-Oncology is a copyright of Springer, 2017.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1007/s11060-017-2514-9
DatabaseName	Springer Nature Link CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic ProQuest One Academic Middle East (New) MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1573-7373
EndPage	240
ExternalDocumentID	PMC5543206 28560664 10_1007_s11060_017_2514_9
Genre	Journal Article
GrantInformation_xml	– fundername: The Semmy Foundation (Stichting Semmy) – fundername: Ter Meulen Grant of the Royal Netherlands Academy of Arts and Sciences – fundername: ;
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Y I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z83 Z87 Z8O Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c470t-a916c027599be8be858cb1d12e8c53d3285d1679dd6d0b0d4e35a0aa2d4e95e63
IEDL.DBID	7X7
ISICitedReferencesCount	24
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000407269300026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0167-594X 1573-7373
IngestDate	Tue Nov 04 02:04:25 EST 2025 Fri Sep 05 08:13:26 EDT 2025 Tue Nov 04 21:52:54 EST 2025 Wed Feb 19 02:41:27 EST 2025 Tue Nov 18 20:36:51 EST 2025 Sat Nov 29 01:35:42 EST 2025 Fri Feb 21 02:37:03 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Cox proportional hazards modeling Discrimination Calibration External validation Prognostic modeling
Language	English
License	Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c470t-a916c027599be8be858cb1d12e8c53d3285d1679dd6d0b0d4e35a0aa2d4e95e63
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-3888-0977
OpenAccessLink	https://link.springer.com/10.1007/s11060-017-2514-9
PMID	28560664
PQID	1925766398
PQPubID	37423
PageCount	10
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5543206 proquest_miscellaneous_1904209828 proquest_journals_1925766398 pubmed_primary_28560664 crossref_primary_10_1007_s11060_017_2514_9 crossref_citationtrail_10_1007_s11060_017_2514_9 springer_journals_10_1007_s11060_017_2514_9
PublicationCentury	2000
PublicationDate	2017-08-01
PublicationDateYYYYMMDD	2017-08-01
PublicationDate_xml	– month: 08 year: 2017 text: 2017-08-01 day: 01
PublicationDecade	2010
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States
PublicationTitle	Journal of neuro-oncology
PublicationTitleAbbrev	J Neurooncol
PublicationTitleAlternate	J Neurooncol
PublicationYear	2017
Publisher	Springer US Springer Nature B.V
Publisher_xml	– name: Springer US – name: Springer Nature B.V
References	Ueoka, Nogueira, Campos (CR19) 2009; 281 Barkovich, Krischer, Kun (CR11) 1990; 16 Vergouwe, Royston, Moons (CR14) 2010; 63 Jansen, Veldhuijzen van Zanten, Sanchez Aliaga (CR5) 2015; 17 Jones, Karajannis, Jones (CR4) 2017; 19 Poussaint, Kocak, Vajapeyam (CR20) 2011; 13 Veldhuijzen van Zanten, Jansen, Aliaga (CR3) 2015; 15 Choodari-Oskooei, Royston, Parmar (CR16) 2012; 31 CR18 Baugh, Bartels, Leach (CR7) 2017 Veldhuijzen van Zanten, Baugh, Chaney (CR6) 2017 Royston, Altman (CR15) 2013; 13 Castel, Philippe, Calmon (CR22) 2015; 130 Altman, Vergouwe, Royston (CR9) 2009; 338 Jansen, Veldhuijzen van Zanten, Heymans (CR23) 2016; 131 Louis, Ohgaki, Wiestler (CR12) 2007; 114 Van Houwelingen (CR10) 2000; 19 Royston, Moons, Altman (CR8) 2009; 338 Bartels, Hawkins, Vézina (CR2) 2011; 105 Hargrave, Bartels, Bouffet (CR1) 2006; 7 Janssen, Vergouwe, Donders (CR13) 2009; 55 Su, Gelman, Hill (CR17) 2011; 45 Altman, Royston (CR21) 2000; 19 AJ Barkovich (2514_CR11) 1990; 16 P Royston (2514_CR15) 2013; 13 KJM Janssen (2514_CR13) 2009; 55 DI Ueoka (2514_CR19) 2009; 281 U Bartels (2514_CR2) 2011; 105 SE Veldhuijzen van Zanten (2514_CR6) 2017 P Royston (2514_CR8) 2009; 338 D Castel (2514_CR22) 2015; 130 J Baugh (2514_CR7) 2017 2514_CR18 TY Poussaint (2514_CR20) 2011; 13 C Jones (2514_CR4) 2017; 19 MHA Jansen (2514_CR23) 2016; 131 DG Altman (2514_CR9) 2009; 338 Y Vergouwe (2514_CR14) 2010; 63 M Jansen (2514_CR5) 2015; 17 Y-S Su (2514_CR17) 2011; 45 D Hargrave (2514_CR1) 2006; 7 SEM Veldhuijzen van Zanten (2514_CR3) 2015; 15 DG Altman (2514_CR21) 2000; 19 HC Houwelingen Van (2514_CR10) 2000; 19 B Choodari-Oskooei (2514_CR16) 2012; 31 DN Louis (2514_CR12) 2007; 114 26399631 - Acta Neuropathol. 2015 Dec;130(6):815-27 19477892 - BMJ. 2009 May 28;338:b605 28110411 - J Neurooncol. 2017 Apr;132(2):255-266 19336487 - BMJ. 2009 Mar 31;338:b604 11122504 - Stat Med. 2000 Dec 30;19(24):3401-15 28093680 - J Neurooncol. 2017 Apr;132(2):323-331 16510333 - Lancet Oncol. 2006 Mar;7(3):241-8 10694730 - Stat Med. 2000 Feb 29;19(4):453-73 2132928 - Pediatr Neurosurg. 1990-1991;16(2):73-83 24903904 - Neuro Oncol. 2015 Jan;17(1):160-6 27026412 - Acta Neuropathol. 2016 May;131(5):793-4 23496923 - BMC Med Res Methodol. 2013 Mar 06;13:33 21520455 - Stat Med. 2012 Oct 15;31(23):2627-43 19596181 - J Clin Epidemiol. 2010 Feb;63(2):205-14 17618441 - Acta Neuropathol. 2007 Aug;114(2):97-109 21901544 - J Neurooncol. 2011 Oct;105(1):119-25 18484645 - Cancer. 2008 Aug 1;113(3):566-72 19345380 - J Neurol Sci. 2009 Jun 15;281(1-2):20-3 27282398 - Neuro Oncol. 2017 Feb 1;19(2):153-161 19282357 - Clin Chem. 2009 May;55(5):994-1001 25435089 - Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64 21297126 - Neuro Oncol. 2011 Apr;13(4):417-27
References_xml	– volume: 114 start-page: 97 year: 2007 end-page: 109 ident: CR12 article-title: The 2007 WHO classification of tumours of the central nervous system publication-title: Acta Neuropathol doi: 10.1007/s00401-007-0243-4 – volume: 130 start-page: 815 year: 2015 end-page: 827 ident: CR22 article-title: Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes publication-title: Acta Neuropathol doi: 10.1007/s00401-015-1478-0 – volume: 45 start-page: 1 year: 2011 end-page: 31 ident: CR17 article-title: Multiple imputation with diagnostics (mi)in R: opening windows into the black box publication-title: J Stat Softw doi: 10.18637/jss.v045.i02 – ident: CR18 – volume: 105 start-page: 119 year: 2011 end-page: 125 ident: CR2 article-title: Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG publication-title: J Neurooncol doi: 10.1007/s11060-011-0704-4 – volume: 7 start-page: 241 year: 2006 end-page: 248 ident: CR1 article-title: Diffuse brainstem glioma in children: critical review of clinical trials publication-title: Lancet Oncol doi: 10.1016/S1470-2045(06)70615-5 – volume: 55 start-page: 994 year: 2009 end-page: 1001 ident: CR13 article-title: Dealing with missing predictor values when applying clinical prediction models publication-title: Clin Chem doi: 10.1373/clinchem.2008.115345 – volume: 19 start-page: 3401 year: 2000 end-page: 3415 ident: CR10 article-title: Validation, calibration, revision and combination of prognostic survival models publication-title: Stat Med doi: 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2 – year: 2017 ident: CR6 article-title: Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease publication-title: J Neurooncol – volume: 19 start-page: 453 year: 2000 end-page: 473 ident: CR21 article-title: What do we mean by validating a prognostic model? publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5 – volume: 338 start-page: b605 year: 2009 ident: CR9 article-title: Prognosis and prognostic research: validating a prognostic model publication-title: BMJ doi: 10.1136/bmj.b605 – year: 2017 ident: CR7 article-title: The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease publication-title: J Neurooncol – volume: 13 start-page: 417 year: 2011 end-page: 427 ident: CR20 article-title: MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC) publication-title: Neuro Oncol doi: 10.1093/neuonc/noq200 – volume: 19 start-page: 153 issue: 2 year: 2017 end-page: 161 ident: CR4 article-title: Pediatric high-grade glioma: biologically and clinically in need of new thinking publication-title: Neuro Oncol – volume: 16 start-page: 73 issue: 2 year: 1990 end-page: 83 ident: CR11 article-title: Brain stem gliomas: a classification system based on magnetic resonance imaging publication-title: Pediatr Neurosurg doi: 10.1159/000120511 – volume: 63 start-page: 205 year: 2010 end-page: 214 ident: CR14 article-title: Development and validation of a prediction model with missing predictor data: a practical approach publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2009.03.017 – volume: 31 start-page: 2627 year: 2012 end-page: 2643 ident: CR16 article-title: A simulation study of predictive ability measures in a survival model I: explained variation measures publication-title: Stat Med doi: 10.1002/sim.4242 – volume: 131 start-page: 793 year: 2016 end-page: 794 ident: CR23 article-title: Commentary on “Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes” publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1567-8 – volume: 281 start-page: 20 year: 2009 end-page: 23 ident: CR19 article-title: Brainstem gliomas—retrospective analysis of 86 patients publication-title: J Neurol Sci doi: 10.1016/j.jns.2009.03.009 – volume: 17 start-page: 160 year: 2015 end-page: 166 ident: CR5 article-title: Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria publication-title: Neuro Oncol doi: 10.1093/neuonc/nou104 – volume: 13 start-page: 33 year: 2013 ident: CR15 article-title: External validation of a Cox prognostic model: principles and methods publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-13-33 – volume: 338 start-page: b604 year: 2009 ident: CR8 article-title: Prognosis and prognostic research: developing a prognostic model publication-title: BMJ doi: 10.1136/bmj.b604 – volume: 15 start-page: 157 year: 2015 end-page: 164 ident: CR3 article-title: A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands publication-title: Expert Rev Anticancer Ther doi: 10.1586/14737140.2015.974563 – volume: 338 start-page: b605 year: 2009 ident: 2514_CR9 publication-title: BMJ doi: 10.1136/bmj.b605 – year: 2017 ident: 2514_CR7 publication-title: J Neurooncol doi: 10.1007/s11060-017-2372-5 – volume: 338 start-page: b604 year: 2009 ident: 2514_CR8 publication-title: BMJ doi: 10.1136/bmj.b604 – volume: 131 start-page: 793 year: 2016 ident: 2514_CR23 publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1567-8 – volume: 13 start-page: 33 year: 2013 ident: 2514_CR15 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-40 – year: 2017 ident: 2514_CR6 publication-title: J Neurooncol doi: 10.1007/s11060-016-2363-y – volume: 17 start-page: 160 year: 2015 ident: 2514_CR5 publication-title: Neuro Oncol doi: 10.1093/neuonc/nou104 – volume: 281 start-page: 20 year: 2009 ident: 2514_CR19 publication-title: J Neurol Sci doi: 10.1016/j.jns.2009.03.009 – volume: 55 start-page: 994 year: 2009 ident: 2514_CR13 publication-title: Clin Chem doi: 10.1373/clinchem.2008.115345 – volume: 7 start-page: 241 year: 2006 ident: 2514_CR1 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(06)70615-5 – volume: 105 start-page: 119 year: 2011 ident: 2514_CR2 publication-title: J Neurooncol doi: 10.1007/s11060-011-0704-4 – volume: 130 start-page: 815 year: 2015 ident: 2514_CR22 publication-title: Acta Neuropathol doi: 10.1007/s00401-015-1478-0 – volume: 16 start-page: 73 issue: 2 year: 1990 ident: 2514_CR11 publication-title: Pediatr Neurosurg doi: 10.1159/000120511 – volume: 19 start-page: 3401 year: 2000 ident: 2514_CR10 publication-title: Stat Med doi: 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2 – volume: 114 start-page: 97 year: 2007 ident: 2514_CR12 publication-title: Acta Neuropathol doi: 10.1007/s00401-007-0243-4 – ident: 2514_CR18 doi: 10.1002/cncr.23584 – volume: 63 start-page: 205 year: 2010 ident: 2514_CR14 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2009.03.017 – volume: 31 start-page: 2627 year: 2012 ident: 2514_CR16 publication-title: Stat Med doi: 10.1002/sim.4242 – volume: 19 start-page: 153 issue: 2 year: 2017 ident: 2514_CR4 publication-title: Neuro Oncol doi: 10.1093/neuonc/now101 – volume: 45 start-page: 1 year: 2011 ident: 2514_CR17 publication-title: J Stat Softw – volume: 19 start-page: 453 year: 2000 ident: 2514_CR21 publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5 – volume: 13 start-page: 417 year: 2011 ident: 2514_CR20 publication-title: Neuro Oncol doi: 10.1093/neuonc/noq200 – volume: 15 start-page: 157 year: 2015 ident: 2514_CR3 publication-title: Expert Rev Anticancer Ther doi: 10.1586/14737140.2015.974563 – reference: 24903904 - Neuro Oncol. 2015 Jan;17(1):160-6 – reference: 28110411 - J Neurooncol. 2017 Apr;132(2):255-266 – reference: 17618441 - Acta Neuropathol. 2007 Aug;114(2):97-109 – reference: 2132928 - Pediatr Neurosurg. 1990-1991;16(2):73-83 – reference: 19477892 - BMJ. 2009 May 28;338:b605 – reference: 27026412 - Acta Neuropathol. 2016 May;131(5):793-4 – reference: 23496923 - BMC Med Res Methodol. 2013 Mar 06;13:33 – reference: 19336487 - BMJ. 2009 Mar 31;338:b604 – reference: 19596181 - J Clin Epidemiol. 2010 Feb;63(2):205-14 – reference: 11122504 - Stat Med. 2000 Dec 30;19(24):3401-15 – reference: 21297126 - Neuro Oncol. 2011 Apr;13(4):417-27 – reference: 28093680 - J Neurooncol. 2017 Apr;132(2):323-331 – reference: 27282398 - Neuro Oncol. 2017 Feb 1;19(2):153-161 – reference: 26399631 - Acta Neuropathol. 2015 Dec;130(6):815-27 – reference: 19345380 - J Neurol Sci. 2009 Jun 15;281(1-2):20-3 – reference: 21520455 - Stat Med. 2012 Oct 15;31(23):2627-43 – reference: 21901544 - J Neurooncol. 2011 Oct;105(1):119-25 – reference: 25435089 - Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64 – reference: 19282357 - Clin Chem. 2009 May;55(5):994-1001 – reference: 18484645 - Cancer. 2008 Aug 1;113(3):566-72 – reference: 16510333 - Lancet Oncol. 2006 Mar;7(3):241-8 – reference: 10694730 - Stat Med. 2000 Feb 29;19(4):453-73
SSID	ssj0004731
Score	2.3291676
Snippet	We aimed to perform external validation of the recently developed survival prediction model for diffuse intrinsic pontine glioma (DIPG), and discuss its...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	231
SubjectTerms	Adolescent Brain cancer Brain Stem Neoplasms - diagnostic imaging Brain Stem Neoplasms - mortality Brain Stem Neoplasms - therapy Brain tumors Calibration Chemotherapy Child Child, Preschool Clinical Study Cohort Studies Female Glioma Glioma - diagnostic imaging Glioma - mortality Glioma - therapy Humans Image Processing, Computer-Assisted Infant Infant, Newborn Kaplan-Meier Estimate Magnetic Resonance Imaging Male Medicine Medicine & Public Health Neurology Oncology Prognosis Registries Regression Analysis Risk groups Survival
SummonAdditionalLinks	– databaseName: Springer Journals dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RBaFeWqDQBgoaJE6gSHk_ekN0CxyoVuWhvUWO7ZRIbbLa7O7P6m_sjJPsNpQiUSmHlTx2HM1n-_OOPR_AO5lHhesoacdEv-2gyAM7FYlrh34UeYXvE8dXRmwiPj1NptN00t3jbvrT7n1I0szUm8tutHvhQ1ScWcClJrfgIa12Ces1nH3_tbkMGXcihDQDhGkw7UOZf2tiuBjdYpi3D0r-ES01i9DJ7r26_wR2Os6JH1uQPIUHunoGj791UfU9uBp3qaCRYFe2IktYF0jcEFlAZdloLKlrZUUuxVnN4hIazy_K-lJgs6TJhurhbM4NmrpGXucIBd5A2UpjG59AvtFi2h78G4nHXyef8UyfG_k5FJUyNjTXT8bDsufw82T849MXu9NxsGUQOwtbEAWVHB5N01wn9ISJzF3lejqRoa8ID6HiaBCLWzm5owLth8IRwqNfaagj_wWMqrrSB4BFnseulpGMlAwiReROxrkrCkW1tXRDC5zeoZnskpyz1sZFtknPzH7IyA8Z-yFLLXi_rjJrM3z8y_iwR0nWDfYmI5JMuzaieokFb9fFNEw59iIqXS_ZhmZHQqtHNvstqNZvo-_nbWRgQTyA29qAU4APS6ryt0kFTmTQ95zIgg896G50666PePlf1q9g22PUmkOPhzBazJf6NTySq0XZzN-YsXcNRAwsnQ priority: 102 providerName: Springer Nature
Title	External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry
URI	https://link.springer.com/article/10.1007/s11060-017-2514-9 https://www.ncbi.nlm.nih.gov/pubmed/28560664 https://www.proquest.com/docview/1925766398 https://www.proquest.com/docview/1904209828 https://pubmed.ncbi.nlm.nih.gov/PMC5543206
Volume	134
WOSCitedRecordID	wos000407269300026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1573-7373 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004731 issn: 0167-594X databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1573-7373 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004731 issn: 0167-594X databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1573-7373 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0004731 issn: 0167-594X databaseCode: 8C1 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1573-7373 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004731 issn: 0167-594X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB7BLkJceD8Cy8pInEARcV5OuCBYusCBqioP9RY5trNEWpLStPuz-I3MOE67YcVekKqole3Ulj-PP3vs-QCeqzKteKCVL5B--3FVxn4uM-4nUZqGVRQhx9dWbEJMp9likc_chlvnjlUONtEaat0q2iN_hUwEqTHOp9mb5S-fVKPIu-okNK7CPslmE87FQuzuRQqnR4jGIMnjxeDVtFfncC1ER7IoTgHHCo7npQtk8-KZyb8cp3Y-Or71vy25DTcdE2Vve-jcgSumuQvXPztf-z34PXEBohmCse6ll1hbMWSMjGRVNp1hNdaybrCj2bIlyQnDTk7r9qdk3QZNEJZjyxW90Ja1ojuvmWTnsHdmWO-1YHTPxb57tEfJ3n-afWBzc2JF6ZhstM2DM8BsMk67D9-OJ1-PPvpO3cFXsQjWvkRiqshpmuelyfCTZKrkmocmU0mkESWJJh8RSV4FZaBjEyUykDLEb3li0ugB7DVtYx4Bq8pScKNSlWoVpxopnxIll5XG0kbxxINg6NtCudDnpMBxWuyCNhMcCoRDQXAocg9ebIss-7gfl2U-GHq6cCagK3bd7MGzbTIOXvLIyMa0G8qDNjPIcdXrwcMeX9t_w_bT4jL2QIyQt81AgcHHKU39wwYIR4oYhUHqwcsBo-eq9a9GPL68EU_gRkijxZ59PIC99WpjnsI1dbauu9WhHXf2meEzO-KHsP9uMp3N8df8y_c_KTs7zA
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VgigX3g9DgUWCC5WF32sjIYRoSqO2UYSKlJtZ765bS8UOcVLEn-pvZGZtJzUVvfWAlEOkfcS7mZn9xjM7H8BrmUW56yhpc4TfdpBngZ2I2LVDP4q83PcR4ytDNsFHo3gyScZrcNbdhaG0ys4mGkOtKknvyN8hEkFojOdp_HH60ybWKIqudhQajVjs6d-_0GWrPwy38f9943k7g8PPu3bLKmDLgDtzWyAgkhSsS5JMx_gJY5m5yvV0LENf4dOFimITRLXkZI4KtB8KRwgPvyWhjnyc9xpcRzvOydnjE766h8lb_kM0PmESTLooqrmqh74XpYBRXQQXN6R_Dl4AtxdzNP8K1Jrzb-fO_7Zzd-F2i7TZp0Y17sGaLu_DzYM2l-ABnA3aAtgMla1oqKVYlTNExIxoYxa1ZgXuSlGiILNpRZQamh2dFNUPweoFmlgcx6YzmtCMNaRC75lg53TrVLMmKsPoHo-Zu_cOlm0Px1_YV31kSPeYKJXpgyfceNBvewjfrmS3HsF6WZX6CbA8y7irZSQjJYNIIaSVPHNFrnC0lm5ogdPJUirb0u7EMHKSropSk_ilKH4piV-aWPB2OWTa1DW5rPNmJ1lpa-LqdCVWFrxaNqNxooiTKHW1oD54JjgJevUWPG7keflruH5yngMLeE_Slx2o8Hm_pSyOTQF0hMC-50QWbHU6ce6x_rWIp5cv4iVs7B4e7Kf7w9HeM7jlkaaaPM9NWJ_PFvo53JCn86KevTA6z-D7VavKH-DglJw
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VgiouvB-GAosEF5BV2-snEkKoSSAqRBECKTd3vbsulood4qSIP8UP4Ncxs7aTmoreekDKIdI-4t3MzH7jmZ0P4JnMwtx1lLQjhN-2n2e-nYjYtQMehl7OOWJ8Zcgmoskkns2S6Rb87u7CUFplZxONoVaVpHfke4hEEBrjeRrv5W1axHQwejP_bhODFEVaOzqNRkQO9M8f6L7Vr8cD_K-fe95o-Hn_vd0yDNjSj5ylLRAcSQrcJUmmY_wEscxc5Xo6lgFX-KSBojgF0S45maN8zQPhCOHhtyTQIcd5L8HliIecHL94f5Ne4kctFyIaoiDxZ11E1VzbQz-M0sGoRoKLm9M_E88A3bP5mn8Fbc1ZOLr-P-_iDbjWInD2tlGZm7Cly1uw87HNMbgNv4ZtYWyGSlg0lFOsyhkiZUZ0MqtaswJ3qChRwNm8IqoNzY6Oi-qbYPUKTS-OY_MFTWjGGrKhV0ywUzp3olkTrWF0v8fM3Xs3ywbj6Tv2SR8ZMj4mSmX64Mk3Hfbb7sCXC9mtu7BdVqW-DyzPssjVMpShkn6oEOrKKHNFrnC0lm5ggdPJVSrbku_EPHKcbopVkyimKIopiWKaWPBiPWTe1Ds5r_NuJ2Vpa_rqdCNiFjxdN6PRokiUKHW1oj54VjgJevsW3Gtke_1ruH5yqn0Lop7UrztQQfR-S1l8NYXRERpzzwkteNnpx6nH-tciHpy_iCewgxqSfhhPDh7CVY-U1qR_7sL2crHSj-CKPFkW9eKxUX8GhxetKX8A1XidIw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=External+validation+of+the+diffuse+intrinsic+pontine+glioma+survival+prediction+model%3A+a+collaborative+report+from+the+International+DIPG+Registry+and+the+SIOPE+DIPG+Registry&rft.jtitle=Journal+of+neuro-oncology&rft.au=Veldhuijzen+van+Zanten%2C+Sophie+E%3B+M&rft.au=Lane%2C+Adam&rft.au=Heymans%2C+Martijn+W&rft.au=Baugh%2C+Joshua&rft.date=2017-08-01&rft.pub=Springer+Nature+B.V&rft.issn=0167-594X&rft.eissn=1573-7373&rft.volume=134&rft.issue=1&rft.spage=231&rft_id=info:doi/10.1007%2Fs11060-017-2514-9&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-594X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-594X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-594X&client=summon